WR
The startup develops gene therapy drugs using AAV and non-viral vectors to treat chronic diseases across various fields, including ophthalmology and cardiovascular health. By focusing on affordable gene therapy solutions, the company aims to improve patient outcomes for conditions that currently lack effective treatments.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops gene therapy drugs using AAV and non-viral vectors to treat chronic diseases across various fields, including ophthalmology and cardiovascular health. By focusing on affordable gene therapy solutions, the company aims to improve patient outcomes for conditions that currently lack effective treatments.